Tuesday 17, Nov 2009
Rituximab is safe and effective for treating rheumatoid arthritis
Posted Byi steroids
As per the biggest study of its kind, rituximab that is used to treat rheumatoid arthritis (RA) is safe and effective at the same time. The results of this study were presented for the first time at the Annual European Congress of Rheumatology, EULAR 2005, in Vienna.
It was remarked by lead author, Professor Paul Emery from the University of Leeds in the UK, of the DANCER Study (Double blind placebo controlled dose ranging study) that rituximab is very much effective and better option than a placebo.
From News-Medical.Net:
Professor Paul Emery from the University of Leeds in the UK led the DANCER study (Double blind placebo controlled dose ranging study), designed to confirm the efficacy of rituximab for the treatment of patients with active RA who have failed to improve on one or more disease modifying anti-rheumatic drugs (DMARDs). Rituximab targets a specific type of immune cell and helps to control inflammation and pain.
The DANCER study involved 465 men and women who had had arthritis for about 10 years. It examined the relative efficacy of two different dose levels of rituximab, as well as the role of anti-inflammatory drugs, glucocorticoids (steroids), in the treatment programme.
Professor Emery said that findings of this study clearly suggest that rituximab is safe and well-tolerated for patients with rheumatoid arthritis.
Tags: glucocorticoids, placebo, Rheumatoid arthritis, rituximab, steroids
Posted in Steroid Cycles, Steroids and Anabolic Steroids, buy steroids, steroid nation | No Comments/Questions


















































According to a published study in an edition of the Journal of Biological Chemistry, researchers have been successful in discovering how
According to Dr. Deborah Symmons, MD and Dr. Susan Verstappen, MD, chief investigators from the University of Manchester in Manchester, United Kingdom, the earlier a patient receives
In a study conducted by medical team headed by Dr. Eva Baecklund of Uppsala University Hospital in Sweden, anew aspect of treatment was found. Patients with severe
Rheumatoid arthritis (RA) is a chronic disease in which the body’s immune system attacks and destroys healthy joint tissue. The hands and feet are frequently affected, and as the disease progresses it can cause pain, swelling, deformity and disability.
As per a new review of evidence, low doses of
There had been significant development in the life of the people suffering from the rheumatoid arthritis as the 